Enko®, founded in 2017, is an innovative player in the Agriculture, Analytics, Biotechnology, and AgriTech sectors. Headquartered in the United States, the company is on a mission to revolutionize crop health through an AI-driven approach. By borrowing pharmaceutical drug discovery methods and applying them to agriculture, Enko® aims to deliver solutions that address critical issues like pest resistance and emerging diseases.
The credibility and potential of Enko® are underscored by backing from prominent investors, including the Bill & Melinda Gates Foundation, Anterra Capital, and Rabo Food & Agri Innovation Fund. Their latest funding injection of $10.00M Series C on 31 January 2023 from investors like Eight Roads Ventures and Nufarm is a testament to the growth prospects envisioned by these strategic partners.
Overall, Enko®'s proven leadership and cutting-edge technology position it as a compelling investment for those looking to support sustainable agricultural innovations.